Patent details

EP2791122 Title: CRYSTALLINE FORM OF CABAZITAXEL AND PROCESS FOR PREPARING THE SAME

Basic Information

Publication number:
EP2791122
PCT Application Number:
IB2012057170
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP128158250
PCT Publication Number:
WO2013088335
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORM OF CABAZITAXEL AND PROCESS FOR PREPARING THE SAME
French Title of Invention:
FORME CRISTALLINE DU CABAZITAXEL ET SON PROCÉDÉ DE PRÉPARATION
German Title of Invention:
KRISTALLINE FORM VON CABAZITAXEL UND HERSTELLUNGSVERFAHREN DAFÜR
SPC Number:

Dates

Filing date:
11/12/2012
Grant date:
23/01/2019
EP Publication Date:
22/10/2014
PCT Publication Date:
20/06/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/01/2019
EP B1 Publication Date:
23/01/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/12/2019
Expiration date:
11/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/01/2019
 
 

Name:
Aventis Pharma S.A.
Address:
20, avenue Raymond Aron, 92160 Antony, France (FR)

Inventor

1

Name:
ZASKE, Lionel
Address:
France (FR)

2

Name:
DIDIER, Eric
Address:
France (FR)

3

Name:
TREMAUDEUX, Nicolas
Address:
France (FR)

Priority

Priority Number:
11306644
Priority Date:
13/12/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/337; A61P 35/00; C07D 305/14;

Publication

European Patent Bulletin

Issue number:
201904
Publication date:
23/01/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages